Cannabix Technologies Inc. reported that the United States Patent and Trademark Office (USPTO) has granted a patent entitled, “Contact-Free Breath Analysis Device and Method” to the Company.
This patent focuses on Cannabix’s innovations. It highlights dual mode contactless and traditional mouthpiece breath capture and analysis technology. This technology is used inside the Company’s BreathLogix device platform. It holds the potential for wide-ranging utility (See Figure 1). The technology can be integrated into everyday environments such as vehicles, workplaces, or public kiosks, and it supports fast, reliable testing without requiring physical contact. The technology can be used in unmanned breath devices; it offers real-time feedback through visual indicators and displays. The system intelligently adjusts its internal airflow and pump mechanisms based on the sampling method, ensuring accurate and hygienic analysis. Cannabix’s design is compact and modular and well-suited for applications in law enforcement, workplace safety, and public health monitoring.
Rav Mlait, CEO, stated, “We are very pleased to add this important innovation to our patent portfolio. This patent grant enhances Cannabix’s leadership in the world of breath sampling and detection techniques.”
